Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus
- 1 November 2003
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 362 (9398), 1850-1853
- https://doi.org/10.1016/s0140-6736(03)14907-0
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1The Lancet, 2003
- Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, ZambiaAIDS, 2003
- HIV-1/AIDS and maternal and child health in AfricaThe Lancet, 2002
- A Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1New England Journal of Medicine, 2000
- Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan AfricaThe Lancet, 1999
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trialThe Lancet, 1999
- Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trialThe Lancet, 1999
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994